Bergsdorf Christian, Fiez-Vandal Cédric, Sykes David A, Bernet Pascal, Aussenac Sonia, Charlton Steven J, Schopfer Ulrich, Ottl Johannes, Duckely Myriam
Novartis Institutes for BioMedical Research (NIBR), Center for Proteomic Chemistry, Switzerland
Novartis Institutes for BioMedical Research (NIBR), Center for Proteomic Chemistry, Switzerland Current affiliation: Heptares Therapeutics Ltd, BioPark, Welwyn Garden City, Hertfordshire, UK.
J Biomol Screen. 2016 Mar;21(3):243-51. doi: 10.1177/1087057115619597. Epub 2015 Dec 7.
Integral membrane proteins (IMPs) play an important role in many cellular events and are involved in numerous pathological processes. Therefore, understanding the structure and function of IMPs is a crucial prerequisite to enable successful targeting of these proteins with low molecular weight (LMW) ligands early on in the discovery process. To optimize IMP purification/crystallization and to identify/characterize LMW ligand-target interactions, robust, reliable, high-throughput, and sensitive biophysical methods are needed. Here, we describe a differential scanning fluorimetry (DSF) screening method using the thiol-reactive BODIPY FL-cystine dye to monitor thermal unfolding of the G-protein-coupled receptor (GPCR), CXCR2. To validate this method, the seven-transmembrane protein CXCR2 was analyzed with a set of well-characterized antagonists. This study showed that the new DSF assay assessed reliably the stability of CXCR2 in a 384-well format. The analysis of 14 ligands with a potency range over 4 log units demonstrated the detection/characterization of LMW ligands binding to the membrane protein target. Furthermore, DSF results cross-validated with the label-free differential static light scattering (DSLS) thermal denaturation method. These results underline the potential of the BODIPY assay format as a general tool to investigate membrane proteins and their interaction partners.
整合膜蛋白(IMPs)在许多细胞活动中发挥着重要作用,并参与众多病理过程。因此,了解IMPs的结构和功能是在发现过程早期成功地用低分子量(LMW)配体靶向这些蛋白质的关键前提。为了优化IMP的纯化/结晶以及鉴定/表征LMW配体-靶点相互作用,需要强大、可靠、高通量且灵敏的生物物理方法。在此,我们描述了一种差示扫描荧光法(DSF)筛选方法,该方法使用硫醇反应性BODIPY FL-胱氨酸染料来监测G蛋白偶联受体(GPCR)CXCR2的热解折叠。为了验证该方法,用一组特征明确的拮抗剂对七跨膜蛋白CXCR2进行了分析。这项研究表明,新的DSF测定法能够以384孔板形式可靠地评估CXCR2的稳定性。对14种效力范围超过4个对数单位的配体进行分析,证明了能够检测/表征与膜蛋白靶点结合的LMW配体。此外,DSF结果与无标记差示静态光散射(DSLS)热变性方法进行了交叉验证。这些结果强调了BODIPY测定法作为研究膜蛋白及其相互作用伙伴的通用工具的潜力。